THOMAS MORGAN: Open Payments
NPI 1659084978 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$933 in 53 payments from 15 companies in 2025. Trend: 2023 $280 · 2024 $495 · 2025 $933
Food & beverage: $933
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $333 |
| Novo Nordisk Inc | 9 | $159 |
| Abbott Laboratories | 4 | $89 |
| PFIZER INC. | 4 | $61 |
| Actelion Pharmaceuticals US, Inc. | 2 | $51 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| Astellas Pharma US Inc | 2 | $37 |
| KYOWA KIRIN, INC. | 1 | $27 |
| Eisai Inc. | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
Products named: UBRELVY, VRAYLAR, FREESTYLE LIBRE 3, Ozempic, QULIPTA, ELIQUIS, Veozah, UPTRAVI.
Industry payments across VA — which companies pay providers there.
